maladies – Politique d'accès aux nouvelles thérapies et de prévention contre le cancer

This written question concerns policies for accessing new cancer therapies and cancer prevention strategies. It seeks information on the government's approach to ensuring patients can benefit from innovative treatments and reduce cancer incidence. The question is posed by a Member of Parliament to the government, likely affecting patients, healthcare providers, and the pharmaceutical industry.